Working 60+ hour weeks in Sorrento Valley labs or managing research deadlines takes a real toll
New research published in JACC , the flagship journal of the American College of Cardiology, and presented just last month at the 2024 American Heart Association Scientific Sessions revealed that GLP-1 drugs, including semaglutide, offer cardiovascular benefits beyond weight loss
Originally created for type 2 diabetes treatment, researchers discovered an unexpected benefit: patients taking the drug experienced decreased appetite and subsequent weight loss
Contraindication clarity: Whether the company clearly states who should not use the product
M., Olfson, M., Bateman, B
As a result, many patients: Feel satisfied with smaller meals Experience fewer cravings Consume fewer calories naturally Lose weight steadily over time Semaglutide is the active ingredient in medications such as: Wegovy Ozempic (approved for Type 2 diabetes) Rybelsus (oral formulation) For many Tampa patients, semaglutide serves as an excellent starting point for medically supervised weight loss
